
Pharmacists may be handed power to prescribe Ozempic on NHS
Pharmacists could be given powers to prescribe Ozempic on the NHS under new plans to tackle Britain's obesity crisis.
Wes Streeting, the Health Secretary, is looking at expanding the list of medics who are able to hand out the jab beyond GPs.
The proposals will form part of a 10-year plan to boost the nation's health, which will be unveiled by Sir Keir Starmer on Thursday.
Under the plans, the role of pharmacies in treating more minor conditions will be ramped up to make them a 'major player on NHS front line'. They will be given extra powers to help more patients who are suffering from issues like obesity, asthma, high blood pressure and diabetes.
Mr Streeting said: 'I'm determined to get the care you need as close as possible to your home and, as pillars of our communities, pharmacies will play a vital role.
'The nation's high streets will join the front line of NHS care, as pharmacists get far more power to prescribe and manage a range of health conditions. Our Plan for Change will give patients greater choice and access to the right care, so your healthcare fits around your life – not the other way round.'
Officials confirmed that, as part of the plans, they are exploring giving high street pharmacists the power to prescribe Ozempic over the counter. Ozempic, and a number of other similar products in its class, can currently only be given out on the NHS by a GP or a hospital clinician.
This month, the health service announced that it would start prescribing Mounjaro, another weight-loss drug, for free to severe obesity sufferers. Around 250,000 people with a BMI of 40 or over and at least four conditions relating to obesity, including high blood pressure or heart disease, will benefit.
Britons can also buy Ozempic from licensed online pharmacies, which have prescribing powers, but it typically costs around £200 a month.
Originally designed as a treatment for Type 2 diabetes, it has exploded in popularity recently after being adopted by celebrities and politicians. However, some former users have warned people against taking the jabs because of the side-effects, which can include nausea and vomiting.
Under the new plans, pharmacists will also be encouraged to help obesity sufferers by offering them dietary counselling and lifestyle advice.
Treating obesity costs the NHS around £11 billion a year and rising, which Mr Streeting has warned risks making the health service 'unsustainable'. Rates have doubled since the 1990s, including amongst the young, with more than one in five children now obese by the time they leave primary school.
£215 million is wasted every year
The Health Secretary is leading a push to divert patients with less serious conditions away from GP surgeries and hospitals to alleviate pressure on the NHS.
High street pharmacies will have their role in delivering vaccination programmes and screening for risk of cardiovascular disease expanded.
National Pharmacy Association research, released on Sunday, found that six million hours of A&E time could be saved every year by redirecting people. It said 325,000 people attended a hospital in 2023-24 with a sore throat or cold, 18,000 with insect bites and 196,000 with urinary tract infections.
The NPA has estimated that £215 million is wasted every year treating patients in A&E when they could have attended a pharmacy instead.
Ministers also plan to roll out the introduction of medicine-dispensing robots in high streets to free up pharmacists to spend more time with patients. Such robots are used in Singapore, which Mr Streeting visited last year on a fact-finding mission about the use of technology in health services.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
an hour ago
- Daily Mail
Urgent Ozempic warning every Aussie needs to hear as concerning trend emerges: 'Follow the instructions'
Aussies have been issued a warning about Ozempic as the number of patients being hospitalised for mistakenly overdosing on weight loss medications soars in one state. The NSW Poisons Information Centre received 332 distressed calls in 2024 from patients using semaglutide - a type 2 diabetes injection that trades under brand names such as Ozempic and Wegovy. Calls seeking advice on poisonings from semaglutide spiked by 1,176 per cent in four years, the Daily Telegraph reported Hospital management was required in 21 per cent of cases. In 2020, just 26 residents called the centre for help. NSW Poisons Information Centre senior specialist Genevieve Adamo said semaglutide was a GLP-1 agonist used to treat type 2 diabetes, but more recently had gained popularity among the public for off-label use for weight loss. 'To prevent accidental medication errors from GLP-1 agonists, NSW PIC advises the community to always write down or mark off the dose on a chart and always follow the instructions on the label,' she said. 'Ensure your doctor, diabetes educator, nurse or pharmacist has given you clear instructions on how to use your medicine, particularly on how to load a dose and inject correctly.' Common symptoms of semaglutide overdose include persistent nausea, vomiting, and diarrhoea, as well as intense headaches and hypoglycaemia (blood sugar). More serious side effects that require immediate medical attention include acute pancreatitis and gallstones. Last year, the PBS recorded more than 2.5 million prescriptions across Australia, a massive jump from 45,705 scripts in 2020 when the drug was first listed on the PBS. The Therapeutic Goods Administration (TGA) has not approved Ozempic for weight loss, while Mounjaro and Wegovy can be prescribed for fat-loss purposes in 'very limited' cases. The TGA announced this month that Novo Nordisk, the pharmaceutical company that supplied Ozempic, had doubled the dose contained in the pre-filled pens from 1.5mL to 3mL. The new 3 mL pen landed on chemist shelves this month and injects a slightly larger volume per dose. The TGA urged doctors to warn Ozempic users to 'be careful' and check the dose before administering it. Earlier this month, official data revealed more than 100 deaths in the United Kingdom had now been linked to blockbuster weight loss jabs. Two of the victims were people in their 20s, according to a MailOnline analysis of logs kept by the medicines safety watchdog. The findings come as the Medicines and Healthcare Products Regulatory Agency confirmed at least ten people in the UK who used the injections have died from pancreatitis, a life-threatening inflammation of the pancreas. The country's Royal Osteoporosis Society has also linked weight loss drugs to osteoporosis and increased risk of bone fractures.


Daily Mail
an hour ago
- Daily Mail
EXCLUSIVE I was thrilled after I lost a stone-and-a-half on Ozempic... then I was hit by this common side-effect. This is the revolutionary new tool that changed everything: OLIVIA FALCON
Like thousands of other menopausal women (I'm 51 now), my health and my figure have been transformed by weight-loss injections. I started using Ozempic in April 2023 and I was thrilled to lose a stone-and-a-half in nine months – I now microdose Mounjaro to maintain my weight.


The Independent
2 hours ago
- The Independent
Patients with common eye condition face sight loss due to care delays
Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice Patients with a common eye condition risk losing their sight permanently due to delays in care, experts have warned. The Association of Optometrists (AOP) said the current approach to glaucoma in England is 'failing the public'. It comes as a survey by the organisation found more than half of high street optometrists have witnessed patients going blind from the condition because of late detection or delays in treatment. Glaucoma affects about 700,000 people in the UK. It is caused by fluid building up in the front part of the eye, leading to the optic nerve, which connects the eye to the brain, becoming damaged. The condition does not usually cause any symptoms to begin with and can develop slowly over many years. A report by the Royal College of Ophthalmologists suggests cases could rise by 22% by 2035. AOP chief executive Adam Sampson said: 'The current approach to glaucoma in England is failing the public. 'Each year, people are faced with the reality of permanent sight loss as a direct result of delays to care and inconsistencies in eye care provision. 'But glaucoma services led by optometrists show that it does not need to be this way.' According to the AOP, reforms in Wales in 2022 mean optometrists can offer glaucoma services on the high street, with schemes also running in Scotland and in some areas of England. It is now calling for the Government to commit to a national glaucoma pathway for England, working with high street opticians to ensure patients have equal access to treatment. An AOP survey of 915 optometrists found 54% had witnessed a patient with glaucoma permanently losing their sight in the last year. The poll also found more than six in 10 optometrists believe most of their patients are unaware of the condition or its risk factors, which include age, ethnicity and some medical conditions like diabetes. Mr Sampson added: 'The research we have conducted reveals a national glaucoma pathway in England could free up 300,000 hospital eye appointments and save the NHS over £12m every year. 'We are calling on the Government to act now to overhaul health in England. 'We must ensure high street optometrists can protect the public by detecting, monitoring and treating glaucoma, and ease the burden on hospital eye services.' Matt Weale was diagnosed with glaucoma after a routine eye test in 2021 revealed dangerously high pressure in his left eye. The 54-year-old said: 'By the time I was finally offered a follow-up appointment, my vision had already started to deteriorate. 'I felt like I was falling through the cracks, and it was terrifying – not knowing if I was going to lose my sight because the system was too stretched to see me. 'If I hadn't been able to pay for private care, I truly believe I would have gone blind in my left eye. I lost confidence, I had to give up my job, the things I loved – like playing football and performing.'